Cellular Dynamics (ICEL)

[XenaLives]

Cellular Dynamics International Inc., a publicly traded maker of human cells in industrial quantities, has filed a registration statement with federal securities regulators for the sale of as much as $90 million worth of its stock, U.S. Securities and Exchange Commission documents show.

The Madison company used a shelf registration process, meaning the company may sell the shares to the public "from time to time." CDI would use the net proceeds for general corporate purposes, which may include working capital or capital expenditures.

CDI makes iPS, or human induced pluripotent stem cells and tissue cells. Like embryonic stem cells, these powerful cells can be grown into any of the body's cell types.

The company said late last month it had been granted a U.S. patent on the automated production of cells that can be grown into any of the more than 200 types of cells in the body. The patent positions CDI as the leading supplier of choice for scientists seeking a high-quality, reliable supply of human cells to use for research into new drugs and therapies, and stem cell banking, executives said.

http://www.jsonline.com/business/cellular-dynamics-registers-to-sell-up-to-90-million-in-stock-b99344604z1-273955681.html